{"name":"Longeveron Inc.","slug":"longeveron-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":709000,"revenueGrowth":-42,"grossMargin":0,"rdSpend":12041000,"netIncome":-22704000,"cash":10261000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Lomecel-B medicinal signaling cells","genericName":"Lomecel-B medicinal signaling cells","slug":"lomecel-b-medicinal-signaling-cells","indication":"Other","status":"phase_2"},{"name":"Longeveron Mesenchymal Stem Cells","genericName":"Longeveron Mesenchymal Stem Cells","slug":"longeveron-mesenchymal-stem-cells","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Lomecel-B medicinal signaling cells","genericName":"Lomecel-B medicinal signaling cells","slug":"lomecel-b-medicinal-signaling-cells","phase":"phase_2","mechanism":"Allogeneic mesenchymal stem cells that secrete bioactive factors to modulate immune responses and promote tissue repair.","indications":[],"catalyst":""},{"name":"Longeveron Mesenchymal Stem Cells","genericName":"Longeveron Mesenchymal Stem Cells","slug":"longeveron-mesenchymal-stem-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE45cHRIbHVBWUR4ejdGcWE5VnZhMTR1Ul93bU1DOXV2LWxUWnFjMzZIVEw0bVg5U2s5dHhsOEFMbS1pSEZEVks3aXhLUjV2VDV2WTlIRF82YW51c08yNXgw?oc=5","date":"2026-04-02","type":"pipeline","source":"ChartMill","summary":"LGVN Stock Price, Quote & Chart | LONGEVERON INC-A (NASDAQ:LGVN) - ChartMill","headline":"LGVN Stock Price, Quote & Chart | LONGEVERON INC-A (NASDAQ:LGVN)","sentiment":"neutral"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-03-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8zTFRwVTJpWGZrTGpHSnVKWnAyaHdRLWRLUW1yRVl4dWtmQ1Y5M01JenBzS3NDbkpRLWZJZWI5a1lRYTNGSEVPb1BzNGJlTGRxWmpfcEtSUmJHZk1JTTV5VXRDWEpORWRlT01DWXNR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Longeveron Inc (LGVN) - Stock Titan","headline":"If You Invested $1,000 in Longeveron Inc (LGVN)","sentiment":"neutral"},{"date":"2026-03-17","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNZWIxUEg1aGtxTjl6Q3dnTmR4eDF6SzRSZFFBdGMyT29XWFA1ektoYnVFVWtFenVYbE54b3Q3M2k4SzVaQzNiVjgybmd1dDhkdTNqTVphUUpDeldQSEJtbnB0OEhFNWtHMTNhaXUyT2hvZmJhLXl5aFFCUHROaE5LUC00cU14WDNoUXlneVMzalg2eTRLS0NrVU41aGlDUFVsQXFHdlYyZWpDUUhZekg1dDF2OWNOVVZ3bVJzak85OGI3dzhIMjJfWVd6emF6NzZYSF96ZDd3aTM?oc=5","date":"2026-03-11","type":"pipeline","source":"GlobeNewswire","summary":"Longeveron Announces Closing of Private Placement of up to $30 Million - GlobeNewswire","headline":"Longeveron Announces Closing of Private Placement of up to $30 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNVExmMXAta3VpaUhWVXZQUFR3RkpkT192SkFwZjhoQ3ZHS0tORk1jT2VLMDNJckN6dklaS0x6ZFhaUXFoUm85WmdaeTJMbDFrNHZjVHI4U0FUaGwwVmwzSXBzNE9EcnlYTTZfOW5rTmhFNmVBVEMtLWhlQmdaRjVaT3k3SXFsNUEwbUhiZzh1aGJEM01xRGVFdlAyQjN2dzU3cks3bA?oc=5","date":"2026-03-10","type":"pipeline","source":"MarketBeat","summary":"Best Biotech Stocks To Keep An Eye On - March 10th - MarketBeat","headline":"Best Biotech Stocks To Keep An Eye On - March 10th","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbVJoS20tcUhMc2N1aDBYTVp0WnVDOUZ0ZUo4bjFTRlJoODFUY20zdDMxLXZ6LTZEM1ZIRk9ub2NucGhFVDJmOXFmTFFaVXA0dFdieXM5ajJiOUhmSnhnbTh5NERaOVVGTUV1UTFkakVQSkZrQVc5bUpldm4zRzhZdTVmd0VjV29mbXV2Nms4dmFycHJDeU5YX2t2RGhDblBJY3VPNjR4V20?oc=5","date":"2026-03-10","type":"trial","source":"Stock Titan","summary":"Longeveron secures $15M now, another $15M tied to HLHS trial milestones - Stock Titan","headline":"Longeveron secures $15M now, another $15M tied to HLHS trial milestones","sentiment":"neutral"},{"date":"2026-03-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNY0R2ZzQzb2t5bFZrRkVzTkNac1FqQzhuNlF2Z0ZKZVNTLTB1ZjRXUm9kRElNX0xvN095dFFOcTJBNnlUMVM5SS1rNXlVOGtmNE90RXVZc3Z6eno1eWdOb2RvN2Y0SXJDR1VIcFFBcFR4akhlVUJORl9jOUVyZ0szeEJ0cUVsSDVj?oc=5","date":"2026-02-16","type":"pipeline","source":"citybiz","summary":"Longeveron Appoints Stephen Willard as CEO - citybiz","headline":"Longeveron Appoints Stephen Willard as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQYVhOZG83WHA3aVJJRm1USDNtdjllUDZ6MVV1MWhuVTFqbVVSX1NobXhJQkg3TTVHdnozSFVrenVxbG1wem83RWEzLXNCWm53R1pJYVNhMWp4X21UTFNTbFhNZjgtMnVvTFpSSGxxbm5VbUtuS1RUNzQyRWxpMllmSGVBYnRTSUVsdlE2OVJMeTJlREN1OGFfbFdQOWdiZ0RDVWlnQ1gwUlpqbHJkTDVnWWc1UQ?oc=5","date":"2026-02-13","type":"pipeline","source":"Quiver Quantitative","summary":"Longeveron Inc. Appoints Stephen H. Willard as New CEO, Succeeding Than Powell - Quiver Quantitative","headline":"Longeveron Inc. Appoints Stephen H. Willard as New CEO, Succeeding Than Powell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQTmRPSzlsNmdKNjRBUENXTWI2cDFJb1hRSGVBYzJSTDZKaWdFNHR5WDJ6UUJiMVN4OElXcEZ5VnFiMVNGZFVNc0lIVVVUVWRvOU9aMGxxaGRQTURnVU0yQUwzR3ZUSXY4X3FnVEd0UTV0YkdoT3A0MmFSbE84OVJEWDllSWxWRTlUVVNma0d6TW9FczVmUC0xbkNNWGZVZ0EzbDE3UExScXZ2dlptS3J0akNTN1JkV1hOejYxeDJlbjd2R3dvSFE3Y0pTcjh4czQ?oc=5","date":"2026-02-13","type":"trial","source":"Investing.com","summary":"Longeveron appoints Stephen Willard as new CEO ahead of pivotal trial results - Investing.com","headline":"Longeveron appoints Stephen Willard as new CEO ahead of pivotal trial results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQWjMwZm1NVjBnM1k2MWFsV1FDdjZvN2NGUG9fbkRhNEhUZ2FKQ1BSclpZOHVkMS1COU1GcngxTmJnZzU2cjR6MktWUGh0bVM4WEJQSDU4TERnd1Z0dkZhRmxFbGRYdUNEWHI4MTh3aEtpV05FVk90WjBXVHNRUGR5a2RmSWhhWDhJa3ZGWFBIVDEyNGVOc1RiUGZqOEx1R3lzZEVOdHVWVEE5SWlJNXN2VQ?oc=5","date":"2026-02-13","type":"trial","source":"Stock Titan","summary":"New Longeveron CEO steps in as pivotal stem cell trial nears - Stock Titan","headline":"New Longeveron CEO steps in as pivotal stem cell trial nears","sentiment":"neutral"},{"date":"2026-02-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":2,"visitCount":11,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":709000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":709000,"period":"2023-12-31"},{"value":1222000,"period":"2022-12-31"},{"value":1222000,"period":"2022-12-31"},{"value":1306000,"period":"2021-12-31"},{"value":1306000,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":12041000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-22704000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":10261000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}